| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/15/1994 | EP0600974A1 Preparation of medicaments containing the peptidoglycan monomer or its derivatives |
| 06/15/1994 | EP0600973A1 A method for treatment of metabolic disorders and metabolism |
| 06/15/1994 | EP0600949A1 New 3,5-di-tert.butyl-4-hydroxyphenyl derivatives, methods of preparing them and drugs containing them. |
| 06/15/1994 | EP0600930A1 Diagnosis and treatment of autoimmune diseases |
| 06/15/1994 | EP0600880A1 INTERLEUKIN 1$g(b) PROTEASE AND INTERLEUKIN 1$g(b) PROTEASE INHIBITORS |
| 06/15/1994 | EP0600875A1 Purification of recombinant apolipoprotein e from bacteria |
| 06/15/1994 | EP0600869A1 Synthetic peptides for arterial imaging |
| 06/15/1994 | EP0469017B1 Expression of human apolipoproteins ai-milano in yeast |
| 06/14/1994 | US5321046 Hypocholesterolemic unsymmetrical dithiol ketals |
| 06/14/1994 | US5321019 Bile acid sulfurated derivatives |
| 06/14/1994 | US5321017 Composition comprising fluriprofen and effectively non-antibacterial tetracycline to reduce bone loss |
| 06/14/1994 | US5321008 Administering an insulin and a calcitonin |
| 06/12/1994 | CA2110672A1 Spiro peperidines and holologs which promote release of growth hormone |
| 06/11/1994 | CA2111035A1 Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 06/10/1994 | CA2109771A1 .alpha.-phosphonocarboxylate squalene synthetase inhibitors |
| 06/09/1994 | WO1994012880A2 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 06/09/1994 | WO1994012529A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 06/09/1994 | WO1994012203A1 DRUGS CONTAINING reg PROTEIN AS ACTIVE INGREDIENT |
| 06/09/1994 | WO1994012200A1 Dry mix formulation for bisphosphonic acids |
| 06/09/1994 | WO1994012175A1 Lipid level depressant containing penicillide compound as active ingredient |
| 06/09/1994 | WO1994003177A3 Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them |
| 06/09/1994 | CA2149882A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 06/08/1994 | EP0600372A1 Process for the preparation of proinsulin with correctly linked cystin bridges |
| 06/08/1994 | EP0600371A1 Guanidinyl alkyl-1,1- bis phosphonic acid derivatives, process for their preparation and use |
| 06/08/1994 | EP0600079A1 ORAL 1$g(a)-HYDROXYPREVITAMIN D |
| 06/08/1994 | EP0599987A1 Method for lowering blood lipid levels |
| 06/08/1994 | EP0599878A1 Use of quinozilinederivatives as orexigenics |
| 06/08/1994 | EP0517789B1 Inhibitor of proliferation of endothelial cells |
| 06/08/1994 | CN1087622A Substituted cyclohexane derivative, preparation and application in illness treatment of same |
| 06/08/1994 | CN1087522A Compositions for the treatment and prophylaxis of metabolic disturbances in infants |
| 06/08/1994 | CN1087517A Pharmaceutical preparations for lowering homocysteine levels |
| 06/08/1994 | CN1087481A Novel compositions |
| 06/08/1994 | CA2110729A1 Optically active aminopyridine derivative and use thereof |
| 06/07/1994 | US5318991 Fatty acid treatment to reduce calcium excretion |
| 06/01/1994 | EP0599697A1 Pyrrole derivatives, their preparation and application in therapy |
| 06/01/1994 | EP0599397A1 Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes |
| 06/01/1994 | EP0599203A1 N,N-disubstituted arylcycloacrylamines, their salts, medicines containing these compounds and their use as well as processes for their preparation |
| 06/01/1994 | EP0599114A1 Vitamin D3 analogs |
| 06/01/1994 | EP0598989A1 Nutritional composition and process for its preparation |
| 06/01/1994 | EP0598754A1 Indoles |
| 06/01/1994 | EP0598750A1 Indoles |
| 06/01/1994 | EP0596026A4 Antibiotic feed compositions and method of enhancing feed efficiency and promoting growth in monogastic animals |
| 06/01/1994 | EP0484372B1 Use of sebacic acid and derivatives thereof for the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
| 06/01/1994 | EP0440725B1 Glucan dietary additives |
| 06/01/1994 | EP0321481B1 Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| 06/01/1994 | CN1024790C Urea derivatives and salts thereof and method for producing same |
| 05/31/1994 | US5317029 Treatment and prevention of diseases associated with bone metabolism |
| 05/31/1994 | US5317023 2-Phenyl-(imidazo(4,5-b)pyridyl-methyl-) derivatives; hypertensive agents; cognition activators |
| 05/31/1994 | US5317010 Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment |
| 05/31/1994 | CA1329937C 1-phenyl-3-naphthalenyloxypropanamines |
| 05/26/1994 | WO1994011394A2 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 05/26/1994 | WO1994011370A1 Substituted amino alkyl compounds |
| 05/26/1994 | WO1994011346A1 Aza spiro alkanes derivatives as therapeutic agents |
| 05/26/1994 | WO1994011338A1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacentates or n, n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress |
| 05/26/1994 | WO1994011012A1 Substituted dipeptide analogs promote release of growth hormone |
| 05/26/1994 | WO1994011011A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 05/26/1994 | WO1994011008A1 Fluidized intestinal submucosa and its use as an injectable tissue graft |
| 05/26/1994 | WO1994011006A1 Compositions for the regulation of cytokine activity |
| 05/26/1994 | WO1994002510A3 Analogs of pth |
| 05/26/1994 | DE4239150A1 O-acyl-4-phenyl-cyclohexanol derivs. - are inhibitors of 2,3-epoxy:squalene-lanosterol cyclase and useful as anti-hypercholesterolaemic for treating atherosclerosis |
| 05/26/1994 | CA2149431A1 Use of n-arylmethylene ethylenediamine-triacetates, n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates against oxidizing stress |
| 05/26/1994 | CA2149116A1 Compositions for the regulation of cytokine activity |
| 05/26/1994 | CA2148835A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 05/26/1994 | CA2148582A1 Therapeutic agents |
| 05/26/1994 | CA2147503A1 Substituted dipeptide analogs promote release of growth hormone |
| 05/25/1994 | EP0598093A1 Quinuclidine derivatives as squalene synthetase inhibitors |
| 05/25/1994 | EP0598032A1 Treatment for type ii diabetes |
| 05/25/1994 | CN1024626C Process for preparing tetrahydrobenz |c,d¨ indole serotonin agonists |
| 05/25/1994 | CA2109774A1 Pyrrole derivatives, preparation and therapeutical use thereof |
| 05/24/1994 | US5315017 Peroxidation and eicosanoid biosynthesis inhibition |
| 05/24/1994 | US5315012 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds |
| 05/24/1994 | US5314903 Benzimidazole compounds useful as calcium channel blockers |
| 05/24/1994 | CA1329862C Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
| 05/24/1994 | CA1329774C Methods for the treatment of osteoporosis and related disorders |
| 05/24/1994 | CA1329765C Oral phosphate ion adsorbent |
| 05/21/1994 | CA2108848A1 Vitamin d3 analogs |
| 05/21/1994 | CA2103381A1 N,n-disubstituted arylcycloalkylamines |
| 05/18/1994 | EP0597107A1 Lignan analog, production thereof, and hypolipidemic drug |
| 05/18/1994 | EP0597043A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 05/18/1994 | EP0537139B1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced |
| 05/18/1994 | EP0409949B1 Arylsulphonyl-nitromethanes, process for their preparation and pharmaceutical compositions |
| 05/18/1994 | CN1086821A Novel thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 05/18/1994 | CN1086820A Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them |
| 05/18/1994 | CN1086806A Substituted cyclohexane derivative for treatment of illness |
| 05/18/1994 | CN1086709A Compositions containing retionic acids and tocopherol |
| 05/18/1994 | CN1024555C Process for phenol substituted gem-diphosphonate derivatives |
| 05/17/1994 | US5312985 Method of synthesizing the precursor pyruvamide |
| 05/17/1994 | US5312839 Aminoalkylsulfonic acids for cells |
| 05/17/1994 | US5312836 Short chain triglycerides |
| 05/17/1994 | US5312835 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
| 05/17/1994 | US5312825 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity |
| 05/17/1994 | US5312817 Treatment of fatigue syndrome |
| 05/17/1994 | US5312814 α-phosphonocarboxylate squalene synthetase inhibitors |
| 05/17/1994 | US5312809 Physiologically active substance derived from malt and process for the production thereof |
| 05/17/1994 | US5312626 Lozenge or chewable tablet |
| 05/17/1994 | CA1329609C Araliphatylaminoalkanediphosphonic acids |
| 05/17/1994 | CA1329540C Use of tnf and lt for the preparation of drugs |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010206A1 Intrinsic inhibitors of aldose reductase |
| 05/11/1994 | WO1994010171A1 5-arylindole derivatives and their use as serotonin (5-ht1) agonists |